Search results

Page results

• Rare cases of blood clots and low platelets after vaccination

  UCLH-led research paper outlines mechanism behind rare cases of blood clots and low platelets after vaccination

• New recycling programme to reduce theatre waste

  An exciting new project to recycle packaging from single-use items is projected to reduce the waste being incinerated from UCLH theatres by around 215kg a year.

• £1.5m donation to transform neonatal brain injury research at UCLH

  UCLH Charity is delighted to announce a generous £1.5 million donation from the Bukhman Philanthropies.

• Introduction to the Lymphoedema Service: Face-to-face consultation

  This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.

• Large study highlights disparities in outcomes between patients of different ethnic groups after giving birth

  A large study looking at the experiences of people across England after giving birth by Caesarean section has highlighted disparities in outcomes between patients of different ethnic groups.

• Dr J. S. Risien Russell, one of Britain’s first black consultants, commemorated with portrait

  The new artwork celebrates the pioneering researcher, teacher and neurology consultant at the National Hospital for Neurology and Neurosurgery.

• New framework outlines how to develop, evaluate and monitor surgical robots

  Experts from across the world, led by UCLH and UCL clinicians and scientists, have created a framework to guide the introduction of new and advanced robots for surgical procedures.

• Tandem T:slim software update

  From the 23rd January, there will be a staggered rollout of the Tandem t:slim™ 7.7 Control IQ software.

• Alzheimer’s disease acquired from historic medical treatments

  Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers. 

• World-first CJD treatment shows promising early results

  A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.